Integrum AB Series B Cash Flow Conversion Efficiency

Latest as of June 2026: -0.012x

Integrum AB Series B cash flow conversion efficiency. Based on the latest financial reports, Integrum AB Series B (INTEG-B) has a cash flow conversion efficiency ratio of -0.012x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.16 Million ≈ $-232.34K USD) by net assets (Skr174.19 Million ≈ $18.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Integrum AB Series B (2014–2025)

Cash flow conversion efficiency of Integrum AB Series B from 2014 to 2025. This chart illustrates how Integrum AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Integrum AB Series B share price for real-time trading data and today's change.

Integrum AB Series B Cash Flow Conversion Ratio Explained

Integrum AB Series B cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Integrum AB Series B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integrum AB Series B ranked by their cash flow conversion efficiency. Also see Integrum AB Series B market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shiva Texyarn Limited NSE:SHIVATEX	0.092x
Okong Corporation KQ:045060	0.044x
LS telcom AG XETRA:LSX	0.485x
Aspermont Ltd AU:ASP	0.082x
Trisula Textile Industries Tbk PT JK:BELL	0.074x
DLSI PA:ALDLS	0.178x
Range Capital Acquisition Corp. Ordinary Shares NASDAQ:RANG	147.033x
CNTus Sungjin Co. Ltd. KQ:352700	-0.002x

Annual Cash Flow Conversion Efficiency for Integrum AB Series B (2014–2025)

The table below shows the annual cash flow conversion efficiency of Integrum AB Series B from 2014 to 2025. Review INTEG-B cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr172.01 Million ≈ $18.51 Million	Skr-41.02 Million ≈ $-4.41 Million	-0.239x	-12.53%
2024-12-31	Skr177.88 Million ≈ $19.14 Million	Skr-37.70 Million ≈ $-4.06 Million	-0.212x	-137.47%
2023-12-31	Skr142.79 Million ≈ $15.37 Million	Skr-12.74 Million ≈ $-1.37 Million	-0.089x	+48.96%
2022-12-31	Skr143.53 Million ≈ $15.45 Million	Skr-25.10 Million ≈ $-2.70 Million	-0.175x	-37.73%
2021-12-31	Skr159.74 Million ≈ $17.19 Million	Skr-20.28 Million ≈ $-2.18 Million	-0.127x	+46.48%
2020-12-31	Skr24.29 Million ≈ $2.61 Million	Skr-5.76 Million ≈ $-620.14K	-0.237x	+69.94%
2019-12-31	Skr23.73 Million ≈ $2.55 Million	Skr-18.72 Million ≈ $-2.01 Million	-0.789x	+49.90%
2018-12-31	Skr16.05 Million ≈ $1.73 Million	Skr-25.28 Million ≈ $-2.72 Million	-1.575x	-62.44%
2017-12-31	Skr18.00 Million ≈ $1.94 Million	Skr-17.45 Million ≈ $-1.88 Million	-0.969x	-238.90%
2016-12-31	Skr10.53 Million ≈ $1.13 Million	Skr-3.01 Million ≈ $-324.30K	-0.286x	+88.15%
2015-12-31	Skr1.14 Million ≈ $122.14K	Skr-2.74 Million ≈ $-294.76K	-2.413x	-312.76%
2014-12-31	Skr1.13 Million ≈ $122.04K	Skr-663.00K ≈ $-71.35K	-0.585x	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$23.25 Million

Skr216.03 Million SEK

Market Cap Rank

#24464 Global

#478 in Sweden

Share Price

Skr8.30

Change (1 day)

+1.22%

52-Week Range

Skr6.96 - Skr11.80

All Time High

Skr102.00